معرفی
Mark E. Reeves, MD, PhD, is a Professor at Loma Linda University School of Medicine in Surgery, Medicine, and the Biochemistry Division. He serves as the Director of the Loma Linda University Cancer Center and Vice President for Institutes, overseeing its development into a world-class facility. His work integrates clinical and laboratory research in oncology.
- Doctor of Medicine, Loma Linda University, 1992
- PhD in Molecular Oncology, University of California, Los Angeles, 1990
- Bachelor of Science, Loma Linda University, 1982
Dr. Reeves' research focuses on oncology, particularly the molecular mechanisms of cancer progression and therapy. His recent work includes targeting the DNA helicase CMG complex and NFκB2-driven transcriptional axes in pancreatic cancer, investigating treatment-driven subclonal evolution in AML, and developing nutrient-based immunotherapies to counter the Warburg effect. He also explores dual regulation of mitochondrial and nuclear genomes in AML therapy.
His publications highlight trends in oncology, including acute myeloid leukemia, pancreatic cancer, and drug resistance mechanisms. Key subfields include gene fusions, chimeric RNA variants, and metabolic reprogramming in cancer cells.
Dr. Reeves has led numerous grants and clinical trials, such as federal projects on TSLP in pediatric leukemia, NIH initiatives for student development, and industry-sponsored studies on pancreatic cancer immunotherapy. He mentors researchers and collaborates across institutions.
He oversees the Surgical Oncology Laboratory and contributes to global health initiatives, including cancer care training in Africa. His leadership roles span the American College of Surgeons, Southwest Oncology Group, and editorial boards of journals like Experimental Hematology and Oncology and Journal of GI Oncology.
